Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
Koehler VF, Berg E, Adam P, Weber GL, Pfestroff A, Luster M, Kutsch JM, Lapa C, Sandner B, Rayes N, Fuss CT, Kreissl MC, Hoster E, Allelein S, Schott M, Todica A, Fassnacht M, Kroiss M, Spitzweg C.
Koehler VF, et al. Among authors: adam p.
Thyroid. 2021 Oct;31(10):1531-1541. doi: 10.1089/thy.2021.0091.
Thyroid. 2021.
PMID: 34405734